Company & Sponsor Intelligence
National University Hospital, Singapore
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting1
Completed2
Countries1
Therapeutic footprint
alzheimersautismstroke
Indexed studies
NCT07840586Acceptability and Efficacy of a Culturally Adapted, Low-Frequency Parent-Mediated Early Start Denver Model (ESDM) Versus Standard Care in Young Children With Autism
autism · SingaporeCOMPLETED
autism · SingaporeCOMPLETED
NCT07210528Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study
alzheimers · SingaporePHASE1
alzheimers · SingaporePHASE1
NCT02325427Changes in Brain Activity Associated With Upper Limb Motor Recovery
stroke · SingaporeNA
stroke · SingaporeNA
NCT05659121Improving Mobility Via Robotic Exoskeletons in Local Rehabilitation Settings in Singapore
stroke · SingaporeNA
stroke · SingaporeNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →